Spinal muscular atrophy - onasemnogene abeparvovec - authority application form (PB330)

Use this form to apply for PBS-subsidised gene therapy with onasemnogene abeparvovec for patients with spinal muscular atrophy who weigh 21 kg or less.

Page last updated: 1 November 2026.
QC 62483